Good News For Two German Firms, Bad News For Another

Good News For Two German Firms, Bad News For Another

over 3 years ago1 min

Once upon a time (a.k.a Thursday) two princes among German companies had relatively happy endings to recent trying tales – but one ugly duckling was consigned to oblivion 🧚‍♂️

What does this mean?

Pharmaceutical and life sciences giant Bayer bought US agricultural biotechnology firm Monsanto for $63 billion back in 2018 – but it also took on legal liabilities relating to Monsanto’s weed killer Roundup, which allegedly caused cancer. After paying $80 million to settle some initial lawsuits, 125,000 more quickly piled up. This week, Bayer finally agreed to pay $12 billion to settle three quarters of those claims.

Daily Brief Image

On Thursday, meanwhile, airline Lufthansa’s biggest shareholder gave his blessing to the German government’s $10 billion rescue package, having previously threatened to vote against a deal which sees Germany take a 20% stake in the company 🇩🇪

Why should I care?

It’s fair to say investors dislike uncertainty: for one thing, it reduces their confidence in their forecasts and leaves companies at the mercy of forces outside of their control. That might explain why Bayer’s stock initially rose on Thursday: while the company’s shelling out a lot, at least putting a figure on the furor is something. Similarly, Lufthansa’s 7% rise likely reflects investors’ increased certainty that the airline will go to the ball ✈️

There was no fairytale ending for payments processor Wirecard – which admitted it was missing $2 billion on Monday and filed for insolvency on Thursday 💳 After all, companies that lose so much cash they can’t meet their financial obligations quickly fall prey to wolfish creditors. Traders who briefly thought Wirecard might bounce back were roasted alive: the company’s stock fell a further 70%.

Daily Brief Image
Finimize

BECOME A SMARTER INVESTOR

All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG